 PRA Health Sciences logo 2014 | |
| Company type | Subsidiary |
|---|---|
| Nasdaq: PRAH | |
| Industry | Pharmaceuticals & Biotechnology |
| Founded | 1976 Charlottesville, Virginia, U.S. |
| Headquarters | , U.S. |
Area served | Worldwide |
Key people | Colin Shannon (President and CEO) |
| Revenue | |
Number of employees | 17,000+ [1] |
| Parent | ICON plc |
| Website | prahs |
PRA Health Sciences was a contract research organization (CRO) with headquarters in Raleigh, North Carolina. It was established in 1976 and acquired by ICON in 2021.
PRA was founded as the Anti-Inflammatory Drug Study Group in 1976, renamed PRA in 1982, as it expanded into other therapeutic areas besides inflammation. [2] In 2013 the company was acquired by Kohlberg Kravis Roberts, which brought the company public in November 2014 and maintained shares until September 2019. [3] In August 2017, the company acquired Conshohocken-based real-world healthcare data, analytics, and technology solutions company Symphony Health for US$530 million. [4] PRA's 2018 revenue was US$2.87 billion. [5] PRA was acquired by ICON PLC on 1 July 2021. [6]
